ESR1 and lung carcinoma: The two anti-ERα mouse monoclonal antibodies (ID5 and 6F11) have shown similar immunoreactivity in breast carcinomas [41] and were most frequently used in previous studies on lung carcinomas [14, 16, 19–21].